Condition 1: cardiovascular disease. Condition 2: cardiovascular disease. Ischaemic heart diseases Ischaemic heart diseases
Conditions
Interventions
Intervention 1: Intervention group 1: oral administrations of 600MG N- acetyl cysteine (Avicenna Pharmacy Co.) twice a day for 30 days. Intervention 2: Control group: without drug treatment.
Treatment - Drugs
Intervention group 1: oral administrations of 600MG N- acetyl cysteine (Avicenna Pharmacy Co.) twice a day for 30 days.
Control group: without drug treatment
Sponsors
Lorestan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: Criteria 1. patients with acute coronary syndrome, coronary artery disease, the treating physician to confirm the diagnosis reached. 2 people (women and men) aged 65-18 years able to read and write their own. 3. People who have the full consent to participate in research. 4. People who have a history of these-acetylcysteine ??orally, by injection or inhalation during the first months of treatment have not. 5 people without a history of hypersensitivity reactions after taking it approved acetylcysteine 6. The people who received both medications or substances with antioxidant effects as vitamin E, A or vitamin A, E, vitamin C, at least one month before the quake 7. People with a history of anti-anxiety drugs, have. 8 people aged 65-18 years. 9. The lack of disease HCV +, HBSAg +, HIV +, diabetes, kidney disease, 10 of pregnancy Exclusion criteria (1) patients who can not understand the questions or did not have the time and location aware. 2. Patients in the study were dissatisfied. 3. Patients who withdrew during the study. 4. People who do not consume drugs. 5 people who died during the study. 6. Individuals involved in the research program to improve the quality of life or reduce anxiety, such as health promotion, and rehabilitation and so on are. 7 people in the business week by experts and researchers to track the phone call not to participate or not. 8. ejection fraction less than 40% for the echocardiogram
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Quality of life. Timepoint: After and before of the intervention. Method of measurement: MacNew Questionnaire.;Anxiety level. Timepoint: After and before of the intervention. Method of measurement: Spielberger Questionnaire.;Blood antioxidant biomarker indexes. Timepoint: After and before of the intervention. Method of measurement: biochemical assesing. | — |
Secondary
| Measure | Time frame |
|---|---|
| -. Timepoint: -. Method of measurement: -. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactHamzehe Najafia
Lorestan University of Medical Sciences
Outcome results
None listed